Phase 1 Study of LQT-1213 in Healthy Adults

Clinical trial NCT05759962 · COMPLETED

Trial details

NCT number: NCT05759962
Sponsor: Thryv Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Long QT Syndrome

Start date: 2022-09-14
Primary completion: 2023-03-05
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.